These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Possible carbon sources for increased succinate synthesis in allylisopropylacetamide-treated rats. Shanley BC; Joubert SM Enzyme; 1973; 16(1):176-80. PubMed ID: 4791040 [No Abstract] [Full Text] [Related]
23. Evidence against a regulatory role for heme oxygenase in hepatic heme synthesis. Rothwell JD; Lacroix S; Sweeney GD Biochim Biophys Acta; 1973 May; 304(3):871-4. PubMed ID: 4726863 [No Abstract] [Full Text] [Related]
24. The effects of drugs on the activities of 5-aminolaevulinate synthetase and other enzymes in the pathway of haem biosynthesis. De Matteis F Biochem J; 1972 Nov; 130(2):52P-53P. PubMed ID: 4664578 [No Abstract] [Full Text] [Related]
25. Drugs and porphyria. De Matteis F S Afr Med J; 1971 Sep; ():126-33. PubMed ID: 5150265 [No Abstract] [Full Text] [Related]
26. Studies on the induction of -aminolevulinic acid synthetase iun mouse liver. Gayathri AK; Rao MR; Padmanaban G Arch Biochem Biophys; 1973 Apr; 155(2):299-306. PubMed ID: 4705427 [No Abstract] [Full Text] [Related]
28. Translocation of delta-aminolevulinate synthase from the cytosol to the mitochondria and its regulation by hemin in the rat liver. Yamauchi K; Hayashi N; Kikuchi G J Biol Chem; 1980 Feb; 255(4):1746-51. PubMed ID: 7354050 [No Abstract] [Full Text] [Related]
29. Mechanism of allylisopropylacetamide-induced increase of -aminolevulinate synthetase in liver mitochondria. VI. Multiple molecular forms of -aminolevulinate synthetase in the cytosol and mitochondria of induced cock liver. Oashi A; Kikuchi G Arch Biochem Biophys; 1972 Nov; 153(1):34-46. PubMed ID: 4568260 [No Abstract] [Full Text] [Related]
30. Studies on the mechanism of the conversion of cytosol delta-aminolevulinic acid synthase to the mitochondrial enzyme in the liver of the allylisopropylacetamide-treated rat. Oashi A; Kikuchi G Arch Biochem Biophys; 1977 Jan; 178(2):607-16. PubMed ID: 836047 [No Abstract] [Full Text] [Related]
31. Enzymatic defects in hepatic porphyria. Preliminary observations in patients with porphyria cutanea tarda and variegate porphyria. Pimstone NR; Blekkenhorst G; Eales L Enzyme; 1973; 16(1):354-66. PubMed ID: 4791054 [No Abstract] [Full Text] [Related]
33. Enzymatic formation of zinc-protoporphyrin by rat liver and its potential effect on hepatic heme metabolism. Bloomer JR; Reuter RJ; Morton KO; Wehner JM Gastroenterology; 1983 Sep; 85(3):663-8. PubMed ID: 6873612 [TBL] [Abstract][Full Text] [Related]
35. -aminolevulinic acid synthetase activity in human plasma: relation to erythropoiesis and evidence of induction in erythropoietic porphyria. Miyagi K; Watson CJ Blood; 1972 Jan; 39(1):13-22. PubMed ID: 4536663 [No Abstract] [Full Text] [Related]
36. Accumulation of substrates by mitochondria. van Dam K; Tsou CS Biochim Biophys Acta; 1968 Oct; 162(3):301-9. PubMed ID: 5680276 [No Abstract] [Full Text] [Related]
38. Aetiological relationship between hepatic siderosis and symptomatic porphyria cutanea tarda. Evidence based on work in Durban. Joubert SM; Taljaard JJ; Shanley BC Enzyme; 1973; 16(1):305-13. PubMed ID: 4133881 [No Abstract] [Full Text] [Related]
39. The reversal of experimental porphyria and the prevention of induction of hepatic mixed-function oxidase by acetate. Piper WN; Tephly TR Arch Biochem Biophys; 1974 Sep; 164(1):351-6. PubMed ID: 4372951 [No Abstract] [Full Text] [Related]
40. Permeability properties of mitochondrial membranes and the regulation of haem biosynthesis. Jones MS; Jones OT Biochem Biophys Res Commun; 1970 Nov; 41(4):1072-9. PubMed ID: 5477219 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]